Thanks that was my understanding, interestingly bioshares (they have a model portfolio) sold their LBT holding last year but LBT still subscribe.
Will be interesting to see when they buy back in.
As I said I don't subscribe and don't know numbers on private subscriptions but corporate subscribers are as follows:
Corporate Subscribers: Cogstate, Bionomics, Impedimed, LBT Innovations, Tissue Therapies, Viralytics, Phylogica, pSivida, Benitec BioPharma, Invion, Imugene, Analytica, Circadian Technologies, Reproductive Health Science, Regeneus, Innate Immunotherapeutics, Anatara Life Sciences, ResApp, Pharmaxis, Starpharma, Antisense Therapeutics, Atcor Medical
Thanks that was my understanding, interestingly bioshares (they...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $23.48M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.5¢ | $7.245K | 453.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 426706 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 703052 | 8 |
View Market Depth
| Last trade - 15.37pm 26/07/2024 (20 minute delay) ? |
| LBT (ASX) Chart |